Key Takeaways:
- Clover Health appoints Dr. Shelly Gupta as Chief Medical Officer, aiming to enhance patient care through technology.
- Analysts have set a one-year price target range for Clover Health Investments Corp (CLOV, Financial) between $1.75 and $6.00.
- Current GF Value estimation implies a potential downside for CLOV from its present market price.
Clover Health (CLOV) has announced Dr. Shelly Gupta as its new Chief Medical Officer. With a proven track record in Medicare Advantage, Dr. Gupta's appointment is set to enhance the company's clinical operations and patient care by leveraging data-driven technologies. Her leadership is anticipated to foster better healthcare outcomes for senior populations.
Wall Street Analysts' Predictions for Clover Health
Five analysts have provided a one-year price target for Clover Health Investments Corp (CLOV, Financial), with an average target of $4.15. This suggests a potential upside of 13.39% from the current share price of $3.66. Price estimates range from a low of $1.75 to a high of $6.00. For a more comprehensive analysis, visit the Clover Health Investments Corp (CLOV) Forecast page.
Brokerage Recommendations
The consensus recommendation across five brokerage firms classifies Clover Health Investments Corp's (CLOV, Financial) stock as a "Hold," with an average rating of 2.6 on a scale where 1 is a Strong Buy and 5 is a Sell.
Assessing CLOV's GF Value
According to GuruFocus estimates, the calculated GF Value for Clover Health Investments Corp (CLOV, Financial) in one year is $2.16. This estimate indicates a potential downside of 40.98% from the current trading price of $3.66. The GF Value metric reflects what the stock ought to be worth based on historical trading multiples, past growth, and projected future performance. For further details, explore the Clover Health Investments Corp (CLOV) Summary page.
